This message was sent to ##Email##
|
|
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
Oncology Nurse Advisor
Many palliative care programs utilize interventions such as music and art therapy. These programs provide benefits that augment traditional medicine and have become increasingly popular. Creative art therapy (CAT) comprises a number of artistic concepts: music, dance and movement, yoga, drama, and even creative writing and poetry. Art, however, is the most significant modality because it actually is a psychosocial intervention.
READ MORE
ScienceDaily
Cancer cells in children tend to develop by following four main trajectories — and two of them are linked to relapse of the disease, new research shows. The four strategies can occur simultaneously in a single tumor, according to the study.
READ MORE
|
Promoted by
|
|
|
|
 |
Recent mass casualty incidents in the U.S. have changed the way we think about traumatic injury. Trauma leaders now know that the key to survival for many victims is immediate bleeding control provided by first responders or private citizens.
According to Lenworth Jacobs, MD, MPH, FACS, chairman of the Hartford Consensus and leader of the ACS Stop the Bleed Program, more than half a million people have received hemorrhage control training in the last two years. And while the percentage of Americans who know how to use a tourniquet is still small, there is good reason to believe their training provides a protective effect at the population level against the risk of bleeding out.
Dr. Jacobs will discuss the Stop the Bleed program during his keynote address at this year’s Creighton Trauma Symposium in Omaha, Nebraska. Recently, he spoke with Trauma System News about Stop the Bleed’s origins, goals and accomplishments.
READ MORE
Drug Target Review
Regenerative medicine has emerged as one of the major areas of modern medical therapy. Its primary objective is to restore or establish normal function through the regeneration or replacement of diseased cells, tissues or entire organs. There are a variety of methods and approaches by which this can be achieved. These techniques include cell and gene therapy, tissue engineering or regenerative drug therapy.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
Medical Xpress
Scientists have uncovered a completely new way to make cancers sensitive to treatment — by targeting antenna-like structures on cells. Their study found that drug-resistant cancer cells have more and longer antennae than those which are killed by treatment.
Blocking the growth of antennae reactivated a range of cancer treatments that had stopped working, the team at The Institute of Cancer Research, London, found.
READ MORE
STAT
Immunotherapy is a source of great hope in cancer care. It has rescued some patients from the brink, while giving others a reason to believe that they, too, could beat the long odds.
But these therapies are also creating a vexing dilemma for doctors: Their patients, citing television ads and media accounts of miraculous recoveries, are pushing hard to try them, even when there is little to no evidence the drugs will work for their particular cancer.
READ MORE
Healthline
A survey of veterans showed an increase in “watchful waiting” in prostate cancer treatment. This “wait and see” attitude is spreading.
READ MORE
|
Promoted by
|
|
|
|
 |
NBC News
It wasn’t looking good for Judy Perkins. Her breast cancer had come back with a vengeance after a 2003 mastectomy and she had big tumors in her chest and on her liver. But an experimental new approach that combines new immunotherapy drugs with a tailor-made therapy to boost her own immune system pulled Perkins back from the brink of death.
READ MORE
Medical Xpress
Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified. Now scientists at Duke Cancer Institute have identified mutations for the vast majority of the remaining 20 percent of uncharacterized tumors, which tend to be especially lethal. The findings indicate that these mutations involve a previously unknown disruption of the cell's normal mortality that is governed by components called telomeres.
READ MORE
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast.
Donate today.
|
|
ScienceDaily
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI's Center for Cancer Research (CCR), and the findings were published recently in Nature Medicine.
READ MORE
| ACS CANCER PROGRAMS UPDATES |
The AJCC is considering making the AJCC Cancer Staging Manual, Eighth Edition available in electronic format. We would greatly appreciate your feedback to understand if an electronic version of the 8th Edition would meet an unfulfilled need for our readers and if so, what would be the optimal platform for distribution.
Please take two minutes to complete the brief survey and let us know your thoughts. The survey will close at 12 p.m. CDT, Friday, June 22.
READ MORE
ACS
This is an annual event observed the first Sunday in June. The CoC has designed a poster for download and use in your celebrations in the spring.
2018 National Cancer Survivors Day Poster
2018 National Cancer Survivors Day Poster with crop marks
ACS
The 2018 Cancer Programs Annual Conference: Learn. Interact. Transform will be held in Chicago, Sept. 5-7. Be a part of this exciting conference that is targeted to health care providers committed to providing comprehensive, multidisciplinary, high-quality, patient-centered care. Share your knowledge and expertise with your peers and colleagues by responding to the call for posters. Complete submissions are due by Friday, July 6. For additional information, refer to the Poster/Resource Submission application.
READ MORE
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neo-plastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2, 2018
Special 25 percent discount expires Sept. 30!
Order your copy today.
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
| IMPORTANT DATES AND DEADLINES |
| Date |
Event |
Location |
| July 21-24 |
ACS Quality and Safety Conference
|
Orlando, FL
|
| Sept. 5-7 |
2018 Cancer Programs Conference
|
Chicago, IL
|
| Oct. 21-25 |
ACS Clinical Congress
|
Boston, MA
|
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
